OPK

1.49

2.74% 0.03

Handel nachbörslich: 1.48 -0.01 -0.67%

Opko Health Inc (OPK)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt OPK? Forum Prognose

Schlusskurs vom Vortag:

$1.46

Offen:

$1.46

24-Stunden-Volumen:

2.37M

Relative Volume:

0.90

Marktkapitalisierung:

$1.13B

Einnahmen:

$581.12M

Nettoeinkommen (Verlust:

$-212.92M

KGV:

-5.4419

EPS:

-0.2738

Netto-Cashflow:

$-174.22M

1W Leistung:

+6.38%

1M Leistung:

+18.11%

6M Leistung:

+15.38%

1J Leistung:

+16.28%

1-Tages-Spanne:

$1.46

$1.5189

1-Wochen-Bereich:

$1.355

$1.5189

52-Wochen-Spanne:

$0.9769

$1.60

Opko Health Inc Stock (OPK) Company Profile

Firmenname

Opko Health Inc

Sektor

Healthcare (1105)

Branche

Diagnostics & Research (49)

Telefon

305-575-4181

Adresse

4400 BISCAYNE BLVD., MIAMI, FL

Mitarbeiter

2,275

Twitter

Nächster Verdiensttermin

2026-07-30

Neueste SEC-Einreichungen

OPK's Discussions on Twitter

Compare OPK vs TMO, DHR, IDXX, NTRA, A

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OPK Opko Health Inc	1.49	1.10B	581.12M	-212.92M	-174.22M	-0.2738
TMO Thermo Fisher Scientific Inc	492.20	174.42B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	188.87	126.67B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	549.16	42.70B	4.45B	1.10B	1.06B	13.59
NTRA Natera Inc	259.97	33.62B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	131.63	35.78B	7.23B	1.41B	1.09B	4.979

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-20	Eingeleitet	JP Morgan	Neutral
2025-10-31	Herabstufung	Jefferies	Buy → Hold
2025-04-25	Eingeleitet	JP Morgan	Neutral
2023-06-29	Hochstufung	Barrington Research	Mkt Perform → Outperform
2022-12-15	Eingeleitet	H.C. Wainwright	Buy
2022-01-24	Herabstufung	Barrington Research	Outperform → Mkt Perform
2021-06-21	Eingeleitet	Ladenburg Thalmann	Buy
2019-11-25	Eingeleitet	Piper Jaffray	Overweight
2018-03-02	Herabstufung	JP Morgan	Neutral → Underweight
2017-09-14	Herabstufung	JP Morgan	Overweight → Neutral
2016-06-21	Bestätigt	Standpoint Research	Buy
2016-06-03	Eingeleitet	Standpoint Research	Buy
2016-03-31	Bestätigt	Barrington Research	Outperform
2015-10-16	Eingeleitet	JP Morgan	Overweight
2015-09-11	Herabstufung	Jefferies	Buy → Hold
2015-03-03	Herabstufung	Oppenheimer	Outperform → Perform
2014-05-12	Bestätigt	Oppenheimer	Outperform
2014-03-14	Eingeleitet	Oppenheimer	Outperform
2013-11-13	Bestätigt	Ladenburg Thalmann	Buy
2013-05-30	Bestätigt	Ladenburg Thalmann	Buy
2012-10-22	Eingeleitet	Barrington Research	Outperform
2011-12-01	Bestätigt	Ladenburg Thalmann	Buy
2011-07-14	Eingeleitet	Ladenburg Thalmann	Buy

Alle ansehen

Opko Health Inc Aktie (OPK) Neueste Nachrichten

Jun 22, 2026

Form 4 Opko Health For: 22 June By Investing.com - Investing.com Nigeria

Jun 22, 2026

Director at OPKO (NASDAQ: OPK) receives grant of 60,000 stock options - Stock Titan

Jun 22, 2026

OPKO Health (OPK) director receives 30,000-share stock option award at $1.42 - Stock Titan

Jun 22, 2026

Opko Health (OPK) director Roger Medel receives 30,000 stock options grant - Stock Titan

Jun 22, 2026

Opko Health (OPK) director awarded 30,000 stock options at $1.42 strike - Stock Titan

Jun 22, 2026

OPKO HEALTH (OPK) director receives 80,000-share stock option grant - Stock Titan

Jun 22, 2026

OPKO Health (OPK) director receives stock options for 30,000 shares - Stock Titan

Jun 22, 2026

Jun 20, 2026

OPKO Health (OPK) up 17.1% since last earnings report: Can it continue? - MSN

Jun 20, 2026

Jun 19, 2026

Opko Health Shareholders Back Board, Equity and Auditors - The Globe and Mail

Jun 19, 2026

Jun 18, 2026

Opko Health shareholders elect board and approve key proposals at annual meeting - Investing.com

Jun 18, 2026

OPKO Health (OPK) AGM 2026 Summary - Quartr

Jun 18, 2026

OPK: All proposals passed, with robust pipeline progress and $98M remaining for share repurchases - TradingView

Jun 18, 2026